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This is a retrospective, observational study to evaluate the effect of maternal age on the outcomes of in vitro fertilization and 
embryo transfer (IVF-ET). 11830 IVF-ET cycles from 10268 women were included. Four groups of different maternal age pe-
riods were compared. The groups were 2130 years old group (4549 cycles), 31–35 years old group (4424 cycles), 36–40 
years old group (2429 cycles), and over 40 years old group (428 cycles). The mean starting dose of Gn and mean total dose of 
Gn in each cycle were significantly higher (P<0.01), while the mean retrieved oocyte number was significantly lower (P<0.01) 
in groups of higher maternal age period than those in each of the lower groups. The biochemical pregnancy rate and the clini-
cal pregnancy rate were significantly lower (P<0.01), while the miscarriage rate was significantly higher (P<0.01) in groups of 
higher maternal age period than those in the lower groups. No difference was found in two-pronuclear zygotes (2PN) rate and 
good quality embryo rate among different groups. Birth defect rate was also comparable in the born babies in different groups. 
In the group with patients’ age over 40 years old, the pregnancy rate was 26.87%, the clinical pregnancy rate was 19.39%, 
while the miscarriage rate after clinical pregnancy was 36.14%. To draw the conclusion, patients with higher maternal age had 
worse IVF outcomes. In women of fertile age, patients between 20 and 30 years old have the best IVF outcomes. Patients over 
40 years old have poor IVF outcome and high miscarriage rate, which suggested the necessity of preimplantation genetic 
screening (PGS). 
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Assisted reproductive technologies have helped many fami-
lies to have their healthy offspring during the past decades. 
In vitro fertilization and embryos transfer (IVF-ET) has 
become increasingly popular and the pregnancy rate was 
improved by the development of the technology [1,2]. Many 
women in advanced age want to have babies through IVF. 
However, it has been reported that one of the main limiting 
factors to fertility and reproductive outcomes was female’s 
age [3,4]. 
Advanced maternal age may cause the aging of oocyte 
which will result in abnormal fertilization and development, 
such as polyspermy, division arrest, implantation failure and 
miscarriage. In addition, it has been demonstrated that the 
increasing aneuploidy rates in human oocytes and embryos 
are observed relative to advanced maternal age [5]. 
Women over 38 years old had poor IVF outcomes, espe-
cially in women over 40 years old [6]. Then which age pe-
riod is the best period for pregnancy? Are IVF outcomes 
worse in women between 30 and 35 years old than those in 
women under 30 years old? Not many papers mentioned 
this. 
In this study, we examined the difference of IVF out-
comes among groups of different maternal age periods 
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(21–30, 31–35, 36–40, and over 40) and found that maternal 
age has obvious influence on IVF. 
1  Materials and methods 
All women undergoing IVF in the Centre for Reproductive 
Medicine, Provincial Hospital affiliated to Shandong Uni-
versity between January 2008 and December 2011 were 
included in the retrospective study. All of these women had 
undergone thorough IVF treatment according to established 
protocols.  
Oocyte retrieval was performed 32–36 h after admin-
istration of HCG trigger guiding by standard transvaginal 
ultrasound and plasma LH level. Collected oocytes were 
fertilized in vitro and 1–3 good quality embryos were trans-
ferred on day 3 or day 5. Progesterone was used for luteal 
phase support regularly. Biochemical pregnancy was veri-
fied by plasma -HCG>20 IU L1 14 d after embryo trans-
fer. Clinical pregnancy was defined as pregnancy sac found 
in the uterus using B ultrasound 20 d after biochemical 
pregnancy confirmation. 
1.1  Patients 
A total of 11830 IVF-ET cycles from 10268 women were 
included in this study. The IVF outcomes were analyzed in 
four different groups sorted by the age period. The groups 
were 21–30 years old group (4549 cycles), 31–35 years old 
group (4424 cycles), 36–40 years old group (2429 cycles), 
and over 40 years old group (428 cycles). 
1.2  IVF outcomes measurement 
Fertilization was determined by the presence of pronuclei 
18–20 h after insemination, only the fertilized oocytes with 
two-pronuclear zygotes (2PN) were classified to normal 
fertilized group. The embryos derived from 2PN zygotes 
were graded as good quality when the number of blasto-
meres was between 7 and 12; additionally, all of the blas-
tomeres had equal or almost equal size, and the percentage 
of anucleated fragments was <25% on day 3. 
Miscarriage was defined as a spontaneous loss of a clini-
cal pregnancy before 24 weeks of gestation; birth defect 
was defined as one causing death or serious disability [7]. 
The mean starting dose of Gonadotropin (Gn), mean total 
dose of Gn in each cycle, mean retrieved oocyte number, 
2PN zygotes rate (2PN zygotes number/retrieved oocytes), 
good quality embryo rate (good quality embryo/2PN zy-
gotes), biochemical pregnancy rate (biochemical pregnancy 
cycles/embryo transfer cycles), clinical pregnancy rate 
(clinical pregnancy cycles/biochemical pregnancy cycles), 
miscarriage rate (miscarriage cycles/clinical pregnancy cy-
cles), and birth defect rate were compared among different 
age groups. 
1.3  Statistical analysis 
Statistical analysis was performed with the use of SPSS 
19.0. A P-value of <0.05 was considered to be statistically 
significant. 
1.4  Ethics 
This study was a retrospective analysis on the clinical prac-
tice outcomes and the data of our study were approved by 
the Institutional Review Board of Shandong University. 
2  Results 
A total of 11830 IVF-ET cycles were included in this study. 
The IVF-ET outcomes were analyzed in four different 
groups classified by the age periods. The groups were 
21–30 years old group (4549 cycles), 31–35 years old group 
(4424 cycles), 36–40 years old group (2429 cycles), and 
over 40 years old group (428 cycles).  
As shown in Table 1 and Figures 1–4, the mean starting 
dose of Gn and mean total dose of Gn of each cycle were 
significantly higher (P<0.01) while the number of mean 
retrieved oocyte was significantly lower (P<0.01) in groups 
of higher maternal age period than those in each of the low-
er groups. The biochemical pregnancy rate and the clinical 
pregnancy rate were significantly lower (P<0.01), while the 
miscarriage rate was significantly higher (P<0.01) in groups 
of higher maternal age period than those in each of the low-
er groups. 
No difference was found in 2PN zygotes rate and good 
quality embryo rate among different groups. Birth defect 
rate was also comparable in the born babies. In the group 
with patients’ age over 40 years old, the pregnancy rate was 
26.87%, the clinical pregnancy rate was 19.39%, while the 
miscarriage rate after clinical pregnancy was 36.14 % (Ta-
ble 1, Figure 4). 
3  Discussion 
It is recognized by many reporters that with the increasing 
of maternal age, the IVF outcomes become increasingly 
worse [3]. Some IVF centers even limited the last age for 
IVF as 43 years old [8]. Women with advanced maternal 
age will have poor ovary response during controlled ovary 
hyperstimulation (COH), low retrieved oocyte number, 
lowoocyte fertilization rate, low good quality embryo rate, 
low embryo implantation rate, low pregancy rate, high 
miscarriage rate, high preterm delivery rate and high birth 
defect rate [6,9–12]. 
We found that first of all, in our study, the fertility signifi-
cantly dropped in women over 30 years old, which is earlier 
than some other reports of the late 30s [11]. In our study,  
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Figure 1  Mean Gn starting dose (IU L1) in different maternal age period groups. 
 
 
Figure 2  Mean Gn total dose (IU L1) in different maternal age period groups. 
in women of 31–35 age period undergoing IVF, the mean 
starting dose of Gn and mean total dose of Gnin each cycle 
were significantly higher than those in women of 21–30 age 
period, while the mean retrieved oocyte number was signif-
icantly lower. This is even worse in higher age period. This 
means the ovary poor response starts earlier than we have 
expected. When a woman is over 30 years old with tubal 
factor for infertility, IVF should be suggested rather than 
laparoscopy surgery. It is necessary to suggest women have 
babies earlier than 30 years old. 
Secondly, in our study, the biochemical pregnancy rate 
and the clinical pregnancy rate were significantly lower, 
while the miscarriage rate was significantly higher in women 
with higher maternal age, even in 31–35 age period. It is 
reasonable that the inner quality of oocytes and embryos 
will decrease the implantation rate, hence affecting the 
pregnancy rate. However, the 2PN zygotes rate and the 
good quality embryo rate had no difference among groups 
in our study, which may be because of the score criteria and 
selection system in the lab. 
Another hot point of IVF outcome is the miscarriage rate 
after clinical pregnancy. This is an important aspect of IVF 
achievement rate. Previous studies have suggested an asso-
ciation between the reduced fertility and an increased risk of 
miscarriage [13–15]. We found in our study over 1/3 pa-
tients miscarried after clinical pregnancy in women under- 
 Yan J H, et al.   Sci China Life Sci   August (2012) Vol.55 No.8 697 
 
Figure 3  Mean retrieved oocyte number in different maternal age period groups. 
 
Figure 4  IVF outcomes of different maternal age periods. 
going IVF over 40 years old; this rate is 20.27% in 36–40 
years old group, 13.21% in 3135 years old group and only 
9.27% in 21–30 years old group. In the latter two groups, 
the miscarriage rates after diagnosis of clinical pregnancy 
are comparable to previous reports of natural pregnancy 
(10%–15%) [16–19]. It is reported that genetic abnormali-
ties, uterine anatomical defects, antiphospholipid antibodies, 
environmental factors, advanced maternal age, obesity, en-
dometriosis, etc. may be the possible causes of miscarriage 
in natural and assisted conceptions [20–24]. In our study, 
the higher miscarriage rates in patients over 35 years old 
may mainly result from advanced maternal age and aneu-
ploid embryo since most of the other reasons were excluded 
before IVF cycle starting.  
PGS was encouraged in women over 40 years old [25], 
though the latest meta-analysis discourage the using of PGS 
[26], patients selection is an important procedure in PGS. 
Comparative genomic hybridization (CGH) and array-CGH 
were widely used now for PGS which could make the result 
more sensitive and exact [27–30]. 
Finally, in our study, we found that the birth defect rates 
have a trend to go up by the increasing of maternal age, but 
no significant difference was found. It is a pity that some of 
the pregnancies were still in progress when this paper was 
drafted, so we could not compare the live birth rate or take 
home baby rate with the relatively small number of birth. 
To draw the conclusion, patients with higher maternal 
age had worse IVF outcomes. Patients between 20 and 30  
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66.23% 54.58% 2720 59.79% 2372 52.14% 35.88% 220 9.27% 
0.41% 
(5/1228) 





67.46%# 53.23%# 2501 56.53%** 2143 48.44%** 30.75%** 283 13.21%** 
0.81% 
(9/1118)# 





68.66%# 54.29%# 1153 47.47%** 972 40.02%** 21.22%** 197 20.27%** 
0.86% 
(4/463)s# 





66.37%# 56.13%# 115 26.87%** 83 19.39%** 8.83%** 30 36.14%** 
0.00% 
(0/20) 
a) *, Some pregnancies are still in progress; **, P＜0.01 vs. each of the lower age periods; #, P＞0.05 vs. each of the lower age periods. 
 
years old have the best IVF outcomes in women of fertile 
age. Patients over 40 years old have really poor IVF out-
comes and high miscarriage rate, which suggested the ne-
cessity of preimplantation genetic screening (PGS). 
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